X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1634) 1634
Publication (199) 199
Book Review (14) 14
Book Chapter (8) 8
Dissertation (3) 3
Government Document (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1308) 1308
index medicus (868) 868
female (715) 715
oncology (706) 706
animals (594) 594
receptor, erbb-3 - metabolism (482) 482
receptor, erbb-2 - metabolism (389) 389
cancer (388) 388
signal transduction (378) 378
cell line, tumor (365) 365
male (352) 352
expression (344) 344
research (328) 328
breast cancer (326) 326
mice (325) 325
receptor, erbb-3 - genetics (321) 321
epidermal growth factor (320) 320
receptor, epidermal growth factor - metabolism (299) 299
middle aged (293) 293
cell biology (282) 282
growth-factor receptor (281) 281
phosphorylation (268) 268
biochemistry & molecular biology (263) 263
kinases (261) 261
immunohistochemistry (259) 259
gene expression (254) 254
receptor, erbb-2 - genetics (249) 249
aged (241) 241
adult (234) 234
tumors (234) 234
proteins (230) 230
genetic aspects (222) 222
research article (222) 222
prognosis (219) 219
receptor, epidermal growth factor - genetics (219) 219
egfr (211) 211
ligands (207) 207
skin and connective tissue diseases (205) 205
breast-cancer (199) 199
epidermal-growth-factor (199) 199
mutation (196) 196
receptor, erbb-4 (196) 196
breast neoplasms - pathology (193) 193
gene expression regulation, neoplastic (190) 190
activation (186) 186
medicine (185) 185
breast neoplasms - metabolism (184) 184
health aspects (183) 183
care and treatment (174) 174
analysis (170) 170
erbb3 (160) 160
multidisciplinary sciences (158) 158
tyrosine (150) 150
metastasis (148) 148
article (147) 147
genetics & heredity (144) 144
cell proliferation (142) 142
her3 (141) 141
breast neoplasms - genetics (140) 140
antineoplastic agents - pharmacology (138) 138
her2 (138) 138
survival (135) 135
tyrosine kinase (133) 133
apoptosis (132) 132
receptors (132) 132
erbb-2 protein (130) 130
physiological aspects (130) 130
development and progression (126) 126
science (126) 126
receptor, epidermal growth factor - antagonists & inhibitors (122) 122
aged, 80 and over (121) 121
epidermal growth factor receptors (121) 121
trastuzumab (121) 121
antineoplastic agents - therapeutic use (119) 119
cells (119) 119
erbb-3 protein (119) 119
receptor (119) 119
biology (118) 118
signal transduction - drug effects (118) 118
breast neoplasms - drug therapy (117) 117
heregulin (115) 115
protein (115) 115
therapy (115) 115
chemotherapy (114) 114
factor receptor (113) 113
neuregulin-1 - metabolism (113) 113
lung cancer (111) 111
egf receptor (109) 109
overexpression (109) 109
neoplasms (108) 108
cell proliferation - drug effects (104) 104
gene amplification (102) 102
receptor, erbb-3 (102) 102
tumor cells, cultured (100) 100
receptor, erbb-2 - analysis (97) 97
monoclonal-antibody (96) 96
proto-oncogene proteins c-akt - metabolism (95) 95
rats (95) 95
blotting, western (94) 94
pathology (94) 94
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1635) 1635
Chinese (2) 2
French (1) 1
German (1) 1
Hungarian (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2013, Volume 141, Issue 1, pp. 43 - 53
Trastuzumab is effective in the treatment of HER2/neu over-expressing breast cancer, but not all patients benefit from it. In vitro data suggest a role for... 
p95HER2 | Medicine & Public Health | Oncology | Breast cancer | HER2 | Trastuzumab | HER3 | ADJUVANT CHEMOTHERAPY | EFFICACY | SAFETY | QUANTITATION | MONOCLONAL-ANTIBODY | PERTUZUMAB | FAMILY | ONCOLOGY | COHORT | PLUS | Single-Blind Method | Breast Neoplasms - secondary | Prognosis | Receptor, ErbB-2 - genetics | Receptor, ErbB-3 - analysis | Humans | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Breast Neoplasms - metabolism | Receptor, ErbB-3 - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Peptide Fragments - immunology | Female | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - immunology | Retrospective Studies | Neoplasm Proteins - genetics | Antibodies, Monoclonal - immunology | Fluorescent Antibody Technique, Indirect | Breast Neoplasms - classification | Protein Structure, Tertiary | Antibodies, Monoclonal, Humanized - therapeutic use | Biomarkers, Tumor - analysis | Neoplasm Proteins - biosynthesis | Kaplan-Meier Estimate | Treatment Outcome | Receptor, ErbB-3 - genetics | Breast Neoplasms - drug therapy | Peptide Fragments - analysis | Disease-Free Survival | Breast Neoplasms - genetics | Genes, erbB-2 | Cell Line, Tumor | Breast Neoplasms - mortality | Biomarkers, Tumor - genetics | Decision Trees | Receptor, ErbB-2 - analysis | Biomarkers, Tumor - immunology | Cohort Studies | Care and treatment | Metastasis | Cancer | Preclinical Study
Journal Article
by Wang, S and Huang, X and Lee, C.-K and Liu, B
Oncogene, ISSN 0950-9232, 07/2010, Volume 29, Issue 29, pp. 4225 - 4236
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 2, pp. 463 - 470
Journal Article
Journal Article